Exact Mass: 314.163

Exact Mass Matches: 314.163

Found 138 metabolites which its exact mass value is equals to given mass value 314.163, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Clomipramine

(3-{14-chloro-2-azatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-2-yl}propyl)dimethylamine

C19H23ClN2 (314.155)


Clomipramine, the 3-chloro analog of imipramine, is a dibenzazepine-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, clomipramine does not affect mood or arousal, but may cause sedation. In depressed individuals, clomipramine exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. Tertiary amine TCAs, such as clomipramine, are more potent inhibitors of serotonin reuptake than secondary amine TCAs, such as nortriptyline and desipramine. TCAs also down-regulate cerebral cortical β-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine-H1 receptors, α1-adrenergic receptors and muscarinic receptors, which accounts for their sedative, hypotensive and anticholinergic effects (e.g. blurred vision, dry mouth, constipation, urinary retention), respectively. See toxicity section below for a complete listing of side effects. Clomipramine may be used to treat obsessive-compulsive disorder and disorders with an obsessive-compulsive component (e.g. depression, schizophrenia, Tourettes disorder). Unlabeled indications include panic disorder, chronic pain (e.g. central pain, idiopathic pain disorder, tension headache, diabetic peripheral neuropathy, neuropathic pain), cataplexy and associated narcolepsy, autistic disorder, trichotillomania, onchophagia, stuttering, premature ejaculation, and premenstrual syndrome. Clomipramine is rapidly absorbed from the gastrointestinal tract and demethylated in the liver to its primary active metabolite, desmethylclomipramine. CONFIDENCE standard compound; INTERNAL_ID 570; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8506; ORIGINAL_PRECURSOR_SCAN_NO 8504 CONFIDENCE standard compound; INTERNAL_ID 570; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8514; ORIGINAL_PRECURSOR_SCAN_NO 8513 CONFIDENCE standard compound; INTERNAL_ID 570; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8510; ORIGINAL_PRECURSOR_SCAN_NO 8508 CONFIDENCE standard compound; INTERNAL_ID 570; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8427; ORIGINAL_PRECURSOR_SCAN_NO 8426 CONFIDENCE standard compound; INTERNAL_ID 570; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8459; ORIGINAL_PRECURSOR_SCAN_NO 8457 CONFIDENCE standard compound; INTERNAL_ID 570; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8468; ORIGINAL_PRECURSOR_SCAN_NO 8467 N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors CONFIDENCE standard compound; EAWAG_UCHEM_ID 3669 CONFIDENCE standard compound; INTERNAL_ID 1527 D049990 - Membrane Transport Modulators

   

WIN VI

5-(5-(4-(4,5-Dihydro-2-oxazoly)phenoxy)pentyl)-3-methylisoxazole

C18H22N2O3 (314.163)


   

dapdiamide B

Dapdiamide B; 3-{[(2E)-4-Amino-4-oxobut-2-enoyl]amino}-L-alanyl-L-isoleucine

C13H22N4O5 (314.159)


A member of the family of dapdiamides consisting of alanylisoleucine, in which one of the methyl hydrogens of alanine is replaced by a fumaramoyl group.

   

dapdiamide C

Dapdiamide C; 3-{[(2E)-4-Amino-4-oxobut-2-enoyl]amino}-L-alanyl-L-leucine

C13H22N4O5 (314.159)


A member of the family of dapdiamides consisting of alanylleucine, in which one of the methyl hydrogens of alanine is replaced by a fumaramoyl group.

   

Homochlorcyclizine

1H-1,4-Diazepine,1-[(4-chlorophenyl)phenylmethyl]hexahydro-4-methyl-

C19H23ClN2 (314.155)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Homochlorcyclizine is a diphenylmethylpiperazine H1-antihistamine.↵

   

Perilloside A

2-(hydroxymethyl)-6-{[4-(prop-1-en-2-yl)cyclohex-1-en-1-yl]methoxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


Constituent of Perilla frutescens (perilla). Perilloside A is found in fats and oils and herbs and spices. Perilloside A is found in fats and oils. Perilloside A is a constituent of Perilla frutescens (perilla).

   

(-)-trans-Carveol glucoside

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[(1S,5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


(-)-trans-Carveol glucoside is found in citrus. (-)-trans-Carveol glucoside is a constituent of Citrus species and ginger mint Mentha gentilis cardiaca Constituent of Citrus subspecies and ginger mint Mentha gentilis cardiaca. (-)-trans-Carveol glucoside is found in citrus.

   

(+)-trans-Carveol glucoside

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[(1R,5S)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


(+)-trans-Carveol glucoside is found in citrus. (+)-trans-Carveol glucoside is a constituent of Citrus species Constituent of Citrus subspecies (+)-trans-Carveol glucoside is found in citrus.

   

17-Ethynyl-16-fluoroestradiol

17-ethynyl-16-fluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol

C20H23FO2 (314.1682)


   

7-Methoxy tropisetron

8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 7-methoxy-1H-indole-3-carboxylic acid

C18H22N2O3 (314.163)


   

Gigantamide A

Gigantamide A

C18H22N2O3 (314.163)


   

3,3,6-Trimethyl-5-heptene-1,2,4-triol

3,3,6-Trimethyl-5-heptene-1,2,4-triol

C16H26O6 (314.1729)


   

(2R,3R,4S,5S,6R)-2-[(2E)-4-ethenyl-2,5-dimethylhexa-2,5-dienoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

(2R,3R,4S,5S,6R)-2-[(2E)-4-ethenyl-2,5-dimethylhexa-2,5-dienoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C16H26O6 (314.1729)


   

myrtenol 10-O-beta-D-glucopyranoside|myrtenyl 10-O-beta-D-glucopyranoside|myrtenyl O-beta-D-glucopyranoside

myrtenol 10-O-beta-D-glucopyranoside|myrtenyl 10-O-beta-D-glucopyranoside|myrtenyl O-beta-D-glucopyranoside

C16H26O6 (314.1729)


   

limonen-10-ol 10-O-beta-D-glucopyranoside|Limonene-10-ol 10-O-??-D-glucopyranoside

limonen-10-ol 10-O-beta-D-glucopyranoside|Limonene-10-ol 10-O-??-D-glucopyranoside

C16H26O6 (314.1729)


   

(-)-cis-chrysanthenol-beta-D-galactopyranoside

(-)-cis-chrysanthenol-beta-D-galactopyranoside

C16H26O6 (314.1729)


   

seco-dihydropyrenophorin-1,4-lactone

seco-dihydropyrenophorin-1,4-lactone

C16H26O6 (314.1729)


   

manadoperoxide C

manadoperoxide C

C16H26O6 (314.1729)


   

1,3,5-triphenylpentan-1-one

1,3,5-triphenylpentan-1-one

C23H22O (314.1671)


   

p-menth-1(7),4(8)-diene-3-yl beta-D-glucopyranoside

p-menth-1(7),4(8)-diene-3-yl beta-D-glucopyranoside

C16H26O6 (314.1729)


   

N-[(3E)-4-methylhex-3-enoyl]-L-tryptophan|streptomycindole

N-[(3E)-4-methylhex-3-enoyl]-L-tryptophan|streptomycindole

C18H22N2O3 (314.163)


   

leucomidine C

leucomidine C

C18H22N2O3 (314.163)


   

3alpha,4alpha,8alpha-trihydroxy-10alpha-methoxy-1alpha,5alpha,7alpha,11-betaH-guaia,6,12-olide

3alpha,4alpha,8alpha-trihydroxy-10alpha-methoxy-1alpha,5alpha,7alpha,11-betaH-guaia,6,12-olide

C16H26O6 (314.1729)


   

p-mentha-1(7),8-dien-2-O-beta-D-glucoside

p-mentha-1(7),8-dien-2-O-beta-D-glucoside

C16H26O6 (314.1729)


   

peroxyplakoric ester C

peroxyplakoric ester C

C16H26O6 (314.1729)


   

(-)-trans-verbenol beta-D-glucopyranoside

(-)-trans-verbenol beta-D-glucopyranoside

C16H26O6 (314.1729)


   

O=C(CCCCC(=O)O)CCCCC(CCCCC(=O)O)=O

O=C(CCCCC(=O)O)CCCCC(CCCCC(=O)O)=O

C16H26O6 (314.1729)


   
   
   
   
   

clomipramine

clomipramine

C19H23ClN2 (314.155)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors D049990 - Membrane Transport Modulators

   
   

7-carboxy-N-geranyl-L-gluatamic acid

7-carboxy-N-geranyl-L-gluatamic acid

[C15H24NO6]+ (314.1604)


   

(2R,3R,4S,5S,6R)-2-[(2E)-4-ethenyl-2,5-dimethylhexa-2,5-dienoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major

(2R,3R,4S,5S,6R)-2-[(2E)-4-ethenyl-2,5-dimethylhexa-2,5-dienoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major

C16H26O6 (314.1729)


   

Ala Ala Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]acetyl}pyrrolidine-2-carboxylic acid

C13H22N4O5 (314.159)


   

Ala Ala Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]propanoyl]pyrrolidin-2-yl]formamido}acetic acid

C13H22N4O5 (314.159)


   

Ala Gly Ala Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}propanoyl]pyrrolidine-2-carboxylic acid

C13H22N4O5 (314.159)


   

Ala Gly Pro Ala

(2S)-2-{[(2S)-1-{2-[(2S)-2-aminopropanamido]acetyl}pyrrolidin-2-yl]formamido}propanoic acid

C13H22N4O5 (314.159)


   

Ala Pro Ala Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}propanamido]acetic acid

C13H22N4O5 (314.159)


   

Ala Pro Gly Ala

(2S)-2-(2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}acetamido)propanoic acid

C13H22N4O5 (314.159)


   

Gly Ala Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]propanoyl]pyrrolidine-2-carboxylic acid

C13H22N4O5 (314.159)


   

Gly Ala Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)propanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C13H22N4O5 (314.159)


   

Gly Pro Ala Ala

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}propanamido]propanoic acid

C13H22N4O5 (314.159)


   

Ergoline-1-carboxaldehyde, 8-(hydroxymethyl)-10-methoxy-6-methyl-, (8b)-

Ergoline-1-carboxaldehyde, 8-(hydroxymethyl)-10-methoxy-6-methyl-, (8b)-

C18H22N2O3 (314.163)


   
   
   

Pro Ala Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]acetic acid

C13H22N4O5 (314.159)


   

Pro Ala Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}propanoic acid

C13H22N4O5 (314.159)


   

Pro Gly Ala Ala

(2S)-2-[(2S)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]propanoic acid

C13H22N4O5 (314.159)


   
   

(-)-trans-Carveol glucoside

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[(1S,5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(+)-trans-Carveol glucoside

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[(1R,5S)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

Perilloside A

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(4S)-4-isopropenyl-1-cyclohexenyl]methoxy]tetrahydropyran-3,4,5-triol

C16H26O6 (314.1729)


   

4,4-DI-N-PROPOXYAZOXYBENZENE

4,4-DI-N-PROPOXYAZOXYBENZENE

C18H22N2O3 (314.163)


   

4-isopropyl-2,5-dioxoimidazolidine-1,3-di(propionohydrazide)

4-isopropyl-2,5-dioxoimidazolidine-1,3-di(propionohydrazide)

C12H22N6O4 (314.1702)


   

4-Hydroxy-6,7-diisobutoxy-3-quinolinecarbonitrile

4-Hydroxy-6,7-diisobutoxy-3-quinolinecarbonitrile

C18H22N2O3 (314.163)


   

butyl prop-2-enoate,2-methylidenebutanoic acid,2-methylprop-2-enoic acid

butyl prop-2-enoate,2-methylidenebutanoic acid,2-methylprop-2-enoic acid

C16H26O6 (314.1729)


   
   

dibutyl (Z)-but-2-enedioate,ethenyl acetate

dibutyl (Z)-but-2-enedioate,ethenyl acetate

C16H26O6 (314.1729)


   

Triprolidine hydrochloride

Triprolidine hydrochloride

C19H23ClN2 (314.155)


D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D018926 - Anti-Allergic Agents

   

4-[(2R)-2-(Chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene

4-[(2R)-2-(Chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene

C17H27ClO3 (314.1649)


   

butyl prop-2-enoate,ethenyl acetate,methyl 2-methylprop-2-enoate

butyl prop-2-enoate,ethenyl acetate,methyl 2-methylprop-2-enoate

C16H26O6 (314.1729)


   

SODIUM HEXETH-4 CARBOXYLATE

SODIUM HEXETH-4 CARBOXYLATE

C14H27NaO6 (314.1705)


   

TERT-BUTYL 3-(2-CYANOPROPAN-2-YL)-5-METHOXY-1H-INDOLE-1-CARBOXYLATE

TERT-BUTYL 3-(2-CYANOPROPAN-2-YL)-5-METHOXY-1H-INDOLE-1-CARBOXYLATE

C18H22N2O3 (314.163)


   

butyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate,prop-2-enoic acid

butyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate,prop-2-enoic acid

C16H26O6 (314.1729)


   

1,5-DIPHENYL-3-(P-TOLYL)FORMAZAN

1,5-DIPHENYL-3-(P-TOLYL)FORMAZAN

C20H18N4 (314.1531)


   

Cyclobenzaprine-D3 Hydrochloride

Cyclobenzaprine-D3 Hydrochloride

C20H19ClD3N (314.1629)


   

3,5-DIPHENYL-1-(P-TOLYL)FORMAZAN

3,5-DIPHENYL-1-(P-TOLYL)FORMAZAN

C20H18N4 (314.1531)


   

BIS(4-(VINYLOXY)BUTYL) SUCCINATE

BIS(4-(VINYLOXY)BUTYL) SUCCINATE

C16H26O6 (314.1729)


   

3,5-DIPHENYL-1-(M-TOLYL)FORMAZAN

3,5-DIPHENYL-1-(M-TOLYL)FORMAZAN

C20H18N4 (314.1531)


   

ethane-1,2-diol: hexanedioic acid: 2-(2-hydroxyethoxy)ethanol

ethane-1,2-diol: hexanedioic acid: 2-(2-hydroxyethoxy)ethanol

C12H26O9 (314.1577)


   

Fluoxetine-d5 solution

Fluoxetine-d5 solution

C17H13D5F3NO (314.1654)


   

Pentaethylene glycol monophenyl ether

Pentaethylene glycol monophenyl ether

C16H26O6 (314.1729)


   

Poly(oxy-1,2-ethanediyl), alpha,alpha-1,6-hexanediylbis(omega-((1-oxo-2-propenyl)oxy)

Poly(oxy-1,2-ethanediyl), alpha,alpha-1,6-hexanediylbis(omega-((1-oxo-2-propenyl)oxy)

C16H26O6 (314.1729)


   

(2,3-dipentylphenyl) dihydrogen phosphate

(2,3-dipentylphenyl) dihydrogen phosphate

C16H27O4P (314.1647)


   

3-HYDROXY-N-[3-(4-MORPHOLINYL)PROPYL]-2-NAPHTHALENECARBOXAMIDE

3-HYDROXY-N-[3-(4-MORPHOLINYL)PROPYL]-2-NAPHTHALENECARBOXAMIDE

C18H22N2O3 (314.163)


   

N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine

N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine

C20H18N4 (314.1531)


   

Ethidium

Ethidium

C21H20N3+ (314.1657)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D004396 - Coloring Agents > D005456 - Fluorescent Dyes D004791 - Enzyme Inhibitors

   

Isobacteriochlorin

Isobacteriochlorin

C20H18N4 (314.1531)


   

Bacteriochlorin

Bacteriochlorin

C20H18N4 (314.1531)


   

N~3~-[3-(1h-Indol-6-Yl)benzyl]pyridine-2,3-Diamine

N~3~-[3-(1h-Indol-6-Yl)benzyl]pyridine-2,3-Diamine

C20H18N4 (314.1531)


   

Homochlorcyclizine

1H-1,4-Diazepine,1-[(4-chlorophenyl)phenylmethyl]hexahydro-4-methyl-

C19H23ClN2 (314.155)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

2-(4-Ethenyl-2,5-dimethylhexa-2,5-dienoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

2-(4-Ethenyl-2,5-dimethylhexa-2,5-dienoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(2S,3S)-2-{[(2S)-3-{[(2E)-4-amino-4-oxobut-2-enoyl]amino}-2-azaniumylpropanoyl]amino}-3-methylpentanoate

(2S,3S)-2-{[(2S)-3-{[(2E)-4-amino-4-oxobut-2-enoyl]amino}-2-azaniumylpropanoyl]amino}-3-methylpentanoate

C13H22N4O5 (314.159)


   

(2S,3S)-2-[[(2S)-2-amino-3-[[(E)-4-amino-4-oxobut-2-enoyl]amino]propanoyl]amino]-3-methylpentanoic acid

(2S,3S)-2-[[(2S)-2-amino-3-[[(E)-4-amino-4-oxobut-2-enoyl]amino]propanoyl]amino]-3-methylpentanoic acid

C13H22N4O5 (314.159)


   

[3-Carboxy-2-[4-(carboxymethyl)-3-methylidenepent-4-enoyl]oxypropyl]-trimethylazanium

[3-Carboxy-2-[4-(carboxymethyl)-3-methylidenepent-4-enoyl]oxypropyl]-trimethylazanium

C15H24NO6+ (314.1604)


   

[3-carboxy-2-[(3E,5E)-7-carboxyhepta-3,5-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(3E,5E)-7-carboxyhepta-3,5-dienoyl]oxypropyl]-trimethylazanium

C15H24NO6+ (314.1604)


   

[3-carboxy-2-[(2E,6E)-7-carboxyhepta-2,6-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(2E,6E)-7-carboxyhepta-2,6-dienoyl]oxypropyl]-trimethylazanium

C15H24NO6+ (314.1604)


   

[3-carboxy-2-[(2E,4E)-7-carboxyhepta-2,4-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(2E,4E)-7-carboxyhepta-2,4-dienoyl]oxypropyl]-trimethylazanium

C15H24NO6+ (314.1604)


   

[3-carboxy-2-[(3E,6E)-7-carboxyhepta-3,6-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(3E,6E)-7-carboxyhepta-3,6-dienoyl]oxypropyl]-trimethylazanium

C15H24NO6+ (314.1604)


   

3,7-Dibutyl-3,7-dimethyl-2,6-dihydro-[1,2,4]triazolo[1,2-a][1,2,4]triazole-1,5-dithione

3,7-Dibutyl-3,7-dimethyl-2,6-dihydro-[1,2,4]triazolo[1,2-a][1,2,4]triazole-1,5-dithione

C14H26N4S2 (314.1599)


   

3-[(2-ethyl-1-oxobutyl)amino]-N-(2-furanylmethyl)benzamide

3-[(2-ethyl-1-oxobutyl)amino]-N-(2-furanylmethyl)benzamide

C18H22N2O3 (314.163)


   

N-[2-(3,4-diethoxyphenyl)ethyl]-2-pyridinecarboxamide

N-[2-(3,4-diethoxyphenyl)ethyl]-2-pyridinecarboxamide

C18H22N2O3 (314.163)


   

N-(3-fluoro-4-methylphenyl)-1-(2-pyrimidinyl)-3-piperidinecarboxamide

N-(3-fluoro-4-methylphenyl)-1-(2-pyrimidinyl)-3-piperidinecarboxamide

C17H19FN4O (314.1543)


   

Ala-Gln-Pro

Ala-Gln-Pro

C13H22N4O5 (314.159)


A tripeptide composed of L-alanine, L-glutamine, and L-proline joined in sequence by peptide linkages.

   

1-[(1S,2aR,8bR)-4-acetyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-cyclopropylethanone

1-[(1S,2aR,8bR)-4-acetyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-cyclopropylethanone

C18H22N2O3 (314.163)


   

1-[(1R,2aR,8bR)-4-acetyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-cyclopropylethanone

1-[(1R,2aR,8bR)-4-acetyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-cyclopropylethanone

C18H22N2O3 (314.163)


   

1-[(1R,2aS,8bS)-4-acetyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-cyclopropylethanone

1-[(1R,2aS,8bS)-4-acetyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-cyclopropylethanone

C18H22N2O3 (314.163)


   

1-[(1S,2aS,8bS)-4-acetyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-cyclopropylethanone

1-[(1S,2aS,8bS)-4-acetyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-cyclopropylethanone

C18H22N2O3 (314.163)


   
   
   
   
   
   

12,22-Dihydro-2H,3H-porphine

12,22-Dihydro-2H,3H-porphine

C20H18N4 (314.1531)


   

1-[(S)-(4-chlorophenyl)-phenylmethyl]-4-methyl-1,4-diazepane

1-[(S)-(4-chlorophenyl)-phenylmethyl]-4-methyl-1,4-diazepane

C19H23ClN2 (314.155)


   

7-carboxy-N-geranyl-L-gluatamic acid

7-carboxy-N-geranyl-L-gluatamic acid

C15H24NO6+ (314.1604)


   

dapdiamide C zwitterion

dapdiamide C zwitterion

C13H22N4O5 (314.159)


A peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of dapdiamide C; major species at pH 7.3.

   

dapdiamide B zwitterion

dapdiamide B zwitterion

C13H22N4O5 (314.159)


A peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of dapdiamide B; major species at pH 7.3.

   

(2r,3r,4s,5s,6r)-2-{[(1r,5s)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,5s)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C16H26O6 (314.1729)


   

1,4-bis(acetyloxy)-3,3,6-trimethylhept-5-en-2-yl acetate

1,4-bis(acetyloxy)-3,3,6-trimethylhept-5-en-2-yl acetate

C16H26O6 (314.1729)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1r,5r)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1r,5r)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(2r,4s)-1,4-bis(acetyloxy)-3,3,6-trimethylhept-5-en-2-yl acetate

(2r,4s)-1,4-bis(acetyloxy)-3,3,6-trimethylhept-5-en-2-yl acetate

C16H26O6 (314.1729)


   

4-(5-oxooxolan-2-yl)butan-2-yl 4,7-dihydroxyoct-2-enoate

4-(5-oxooxolan-2-yl)butan-2-yl 4,7-dihydroxyoct-2-enoate

C16H26O6 (314.1729)


   

4,4a,8a-trihydroxy-5-methoxy-4-methyl-3-(3-methylbut-2-en-1-yl)-tetrahydro-1h-2-benzopyran-6-one

4,4a,8a-trihydroxy-5-methoxy-4-methyl-3-(3-methylbut-2-en-1-yl)-tetrahydro-1h-2-benzopyran-6-one

C16H26O6 (314.1729)


   

(2e)-n-[4-(5-hydroxy-3-methyl-2-oxo-5h-pyrrol-1-yl)butyl]-3-phenylprop-2-enimidic acid

(2e)-n-[4-(5-hydroxy-3-methyl-2-oxo-5h-pyrrol-1-yl)butyl]-3-phenylprop-2-enimidic acid

C18H22N2O3 (314.163)


   

5-{[4-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-4,5-dihydro-3h-pyrrole-2,3,4-triol

5-{[4-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-4,5-dihydro-3h-pyrrole-2,3,4-triol

C18H22N2O3 (314.163)


   

2-heptyl-3,4,7-trihydroxy-3,7-dimethyl-2h,4h-furo[3,4-b]pyran-5-one

2-heptyl-3,4,7-trihydroxy-3,7-dimethyl-2h,4h-furo[3,4-b]pyran-5-one

C16H26O6 (314.1729)


   

(3r,4r,5s)-5-{[4-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-4,5-dihydro-3h-pyrrole-2,3,4-triol

(3r,4r,5s)-5-{[4-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-4,5-dihydro-3h-pyrrole-2,3,4-triol

C18H22N2O3 (314.163)


   

2-[(1-hydroxy-4-methylhex-3-en-1-ylidene)amino]-3-(1h-indol-3-yl)propanoic acid

2-[(1-hydroxy-4-methylhex-3-en-1-ylidene)amino]-3-(1h-indol-3-yl)propanoic acid

C18H22N2O3 (314.163)


   

(2r)-4-(5-oxooxolan-2-yl)butan-2-yl (2e,4s,7r)-4,7-dihydroxyoct-2-enoate

(2r)-4-(5-oxooxolan-2-yl)butan-2-yl (2e,4s,7r)-4,7-dihydroxyoct-2-enoate

C16H26O6 (314.1729)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(4s)-4-(prop-1-en-2-yl)cyclohex-1-en-1-yl]methoxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(4s)-4-(prop-1-en-2-yl)cyclohex-1-en-1-yl]methoxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-({2-[(1r)-4-methylcyclohex-3-en-1-yl]prop-2-en-1-yl}oxy)oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-({2-[(1r)-4-methylcyclohex-3-en-1-yl]prop-2-en-1-yl}oxy)oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(5r,8r,16r)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadec-3-ene-2,10-dione

(5r,8r,16r)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadec-3-ene-2,10-dione

C16H26O6 (314.1729)


   

2-(hydroxymethyl)-6-{[2-(4-methylcyclohex-3-en-1-yl)prop-2-en-1-yl]oxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{[2-(4-methylcyclohex-3-en-1-yl)prop-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-{[(2e)-1-hydroxy-3-(c-hydroxycarbonimidoyl)prop-2-en-1-ylidene]amino}propylidene]amino}-3-methylpentanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-{[(2e)-1-hydroxy-3-(c-hydroxycarbonimidoyl)prop-2-en-1-ylidene]amino}propylidene]amino}-3-methylpentanoic acid

C13H22N4O5 (314.159)


   

methyl 3-[(6r)-6-ethyl-11-oxo-7h,8h,9h-pyrido[2,1-b]quinazolin-6-yl]propanoate

methyl 3-[(6r)-6-ethyl-11-oxo-7h,8h,9h-pyrido[2,1-b]quinazolin-6-yl]propanoate

C18H22N2O3 (314.163)


   

(2e)-n-{4-[(5r)-5-hydroxy-3-methyl-2-oxo-5h-pyrrol-1-yl]butyl}-3-phenylprop-2-enimidic acid

(2e)-n-{4-[(5r)-5-hydroxy-3-methyl-2-oxo-5h-pyrrol-1-yl]butyl}-3-phenylprop-2-enimidic acid

C18H22N2O3 (314.163)


   

(3r,4s,4ar,5s,8as)-4,4a,8a-trihydroxy-5-methoxy-4-methyl-3-(3-methylbut-2-en-1-yl)-tetrahydro-1h-2-benzopyran-6-one

(3r,4s,4ar,5s,8as)-4,4a,8a-trihydroxy-5-methoxy-4-methyl-3-(3-methylbut-2-en-1-yl)-tetrahydro-1h-2-benzopyran-6-one

C16H26O6 (314.1729)


   

(2r,3s,4r,7r)-2-heptyl-3,4,7-trihydroxy-3,7-dimethyl-2h,4h-furo[3,4-b]pyran-5-one

(2r,3s,4r,7r)-2-heptyl-3,4,7-trihydroxy-3,7-dimethyl-2h,4h-furo[3,4-b]pyran-5-one

C16H26O6 (314.1729)


   

2-[(1-hydroxyethylidene)amino]-3-[1-(2-methylbut-3-en-2-yl)indol-3-yl]propanoic acid

2-[(1-hydroxyethylidene)amino]-3-[1-(2-methylbut-3-en-2-yl)indol-3-yl]propanoic acid

C18H22N2O3 (314.163)


   

2-(hydroxymethyl)-6-{[2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{[2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H26O6 (314.1729)


   

n-[4-(5-hydroxy-3-methyl-2-oxo-5h-pyrrol-1-yl)butyl]-3-phenylprop-2-enimidic acid

n-[4-(5-hydroxy-3-methyl-2-oxo-5h-pyrrol-1-yl)butyl]-3-phenylprop-2-enimidic acid

C18H22N2O3 (314.163)


   

(2s)-2-{[(3e)-1-hydroxy-4-methylhex-3-en-1-ylidene]amino}-3-(1h-indol-3-yl)propanoic acid

(2s)-2-{[(3e)-1-hydroxy-4-methylhex-3-en-1-ylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C18H22N2O3 (314.163)


   

(2e)-n-{4-[(5s)-5-hydroxy-3-methyl-2-oxo-5h-pyrrol-1-yl]butyl}-3-phenylprop-2-enimidic acid

(2e)-n-{4-[(5s)-5-hydroxy-3-methyl-2-oxo-5h-pyrrol-1-yl]butyl}-3-phenylprop-2-enimidic acid

C18H22N2O3 (314.163)


   

2-({6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl}methoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

2-({6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl}methoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C16H26O6 (314.1729)